Ocular Therapeutix Inc Earnings

The next earnings date for Ocular Therapeutix Inc is August 11, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ocular Therapeutix Inc Earnings

Report DateEstimated Earnings Per Share
11/10/2025$-0.36
08/11/2025$-0.36

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ocular Therapeutix Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/05/2025Before Market$-0.37-33.00%
03/10/2025Before Market$-0.29-31.82%
11/05/2024After Market$-0.228.33%
08/07/2024Before Market$-0.26-18.18%
05/07/2024After Market$-0.70-268.42%
03/11/2024After Market$-0.35-16.67%
11/07/2023After Market$-0.1741.38%
08/07/2023After Market$-0.2613.33%
05/08/2023After Market$-0.39-50.00%
03/06/2023After Market$-0.244.00%
11/07/2022After Market$-0.31-29.17%
08/08/2022After Market$-0.25-8.70%
05/09/2022After Market$-0.1638.46%
02/28/2022After Market$-0.0578.26%
11/08/2021After Market$0.03111.54%
08/09/2021After Market$-0.1147.62%
05/05/2021After Market$0.04119.05%
03/11/2021After Market$-1.21-611.76%
11/05/2020After Market$-0.2112.50%
08/07/2020Before Market$-0.64-106.45%
05/08/2020Before Market$-0.41-10.81%
03/12/2020After Market$-0.53-17.78%
11/12/2019Before Market$-0.4014.89%
08/07/2019After Market$-0.57-18.75%
05/10/2019Before Market$-0.48-14.29%
03/07/2019After Market$-0.42-10.53%
11/07/2018After Market$-0.380.00%
08/07/2018After Market$-0.370.00%
05/08/2018After Market$-0.40-5.26%
03/08/2018Before Market$-0.4415.38%
11/07/2017After Market$-0.54-1.89%
08/08/2017After Market$-0.64-14.29%
05/05/2017Before Market$-0.58-20.83%
03/10/2017Before Market$-0.52-15.56%
11/09/2016Before Market$-0.3922.00%
08/09/2016Before Market$-0.466.12%
05/10/2016Before Market$-0.44-2.33%
03/10/2016Before Market$-0.438.51%
11/10/2015After Market$-0.47-23.68%
08/10/2015After Market$-0.45-36.36%
05/15/2015Before Market$-0.3510.26%
03/10/2015Before Market$-0.372.63%
11/12/2014Before Market$-0.48-11.63%
08/29/2014---$-2.10---

More About Ocular Therapeutix Inc

Country
USA
Full Time Employees
274

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and in Phase 1 clinical trials for the treatment of non-proliferative diabetic retinopathy; PAXTRAVA, a travoprost intracameral hydrogel, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and PAXTRAVA. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Ocular Therapeutix Inc Earnings” Can Refer to the Ocular Therapeutix Inc Earnings Date

Some people say “Ocular Therapeutix Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ocular Therapeutix Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ocular Therapeutix Inc Stock on the Earnings Date

If you own Ocular Therapeutix Inc stock (OCUL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ocular Therapeutix Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ocular Therapeutix Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ocular Therapeutix Inc Earnings

You can contact us any time if you would like to ask questions about Ocular Therapeutix Inc earnings or anything else related to the stock market.